CIK 0001824893 · Non-accelerated filer<br>Smaller reporting company
Surrozen, Inc./DE
Sign in to watch- Ticker
- SRZN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 301374889
- Phone
- 650-475-2820
- Business address
- 171 OYSTER POINT BLVD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Consonance-HFW Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 54 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-15 | Maleki Andrew Pedrum Chief Financial Officer | Grant or award | +607 | $19.01 | $12K | 607 |
| 2026-06-15 | Li Yang Exec. Vice President, Research | Grant or award | +1,666 | $8.11 | $14K | 18,882 |
| 2026-06-15 | Williams Charles O Chief Operating Officer | Grant or award | +1,666 | $8.11 | $14K | 18,237 |
| 2026-06-15 | Parker Craig C Chief Executive Officer | Grant or award | +1,622 | $8.11 | $13K | 18,175 |
| 2026-05-13 | Kutzkey Tim Director | Grant or award · Option (right to buy) | +5,550 | 5,550 | ||
| 2026-05-13 | Rothenberg Mace Director | Grant or award · Director Stock Option (right to buy) | +5,550 | 5,550 | ||
| 2026-05-13 | WOODHOUSE DAVID J Director | Grant or award · Director Stock Option (right to buy) | +5,550 | 5,550 | ||
| 2026-05-13 | Haak-Frendscho Mary Director | Grant or award · Director Stock Option (right to buy) | +5,550 | 5,550 | ||
| 2026-05-13 | CHAI CHRISTOPHER Y Director | Grant or award · Director Stock Option (right to buy) | +5,550 | 5,550 | ||
| 2026-05-13 | BJERKHOLT ERIC Director | Grant or award · Director Stock Option (right to buy) | +5,550 | 5,550 | ||
| 2026-05-13 | Berkenblit Anna Director | Grant or award · Director Stock Option (right to buy) | +5,550 | 5,550 | ||
| 2026-05-04 | Li Yang Exec. Vice President, Research | Sale | −1,584 | $33.33 | $53K | 17,216 |
| 2026-05-04 | Williams Charles O Chief Operating Officer | Sale | −2,036 | $33.33 | $68K | 16,571 |
| 2026-05-04 | Parker Craig C Chief Executive Officer | Sale | −4,524 | $33.33 | $151K | 16,553 |
| 2026-05-01 | Li Yang Exec. Vice President, Research | Option exercise | +4,375 | 18,800 | ||
| 2026-05-01 | Li Yang Exec. Vice President, Research | Option exercise · Restricted Stock Unit | −4,375 | 4,375 | ||
| 2026-05-01 | Williams Charles O Chief Operating Officer | Option exercise | +5,625 | 18,607 | ||
| 2026-05-01 | Williams Charles O Chief Operating Officer | Option exercise · Restricted Stock Unit | −5,625 | 5,625 | ||
| 2026-05-01 | Parker Craig C Chief Executive Officer | Option exercise | +12,500 | 21,077 | ||
| 2026-05-01 | Parker Craig C Chief Executive Officer | Option exercise · Restricted Stock Unit | −12,500 | 12,500 |
Page 2 of 12 · 237 trades